_id

69104d58ccc777a4e85d52d3

Ticker

CGTX

Name

Cognition Therapeutics Inc

Exchange

NASDAQ

Address

2500 Westchester Ave., Purchase, NY, United States, 10577

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cogrx.com

Description

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

Last Close

1.62

Volume

670022

Current Price

1.69

Change

4.3209876543209775

Last Updated

2025-11-29T11:23:39.951Z

Image

data:image/webp;base64,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

Ipo Date

2021-10-08T00:00:00.000Z

Market Cap

153597200

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9844999999999999

Sentiment Sources

4

Rating

4.75

Target Price

3.5

Strong Buy

3

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

61000

Gross Profit

-61000

Operating Expenses

6314000

Operating Income

-6375000

Interest Expense

0

Pretax Income

-4930000

Net Income

-4930000

Eps

-0.06324444273454961

Dividends Per Share

-

Shares Outstanding

88274258

Income Tax Expense

-

EBITDA

-4869000

Operating Margin

-

Total Other Income Expense Net

1445000

Cash

39823000

Short Term Investments

-

Receivables

1900000

Inventories

-

Total Current Assets

42883000

Property Plant Equipment

512000

Total Assets

43395000

Payables

827000

Short Term Debt

168000

Long Term Debt

-

Total Liabilities

6866000

Equity

36529000

Depreciation

61000

Change In Working Capital

-1304000

Cash From Operations

-5651000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

33917000

Net Change In Cash

28266000

PE

-

PB

3.6063964786881653

ROE

-13.496126365353556

ROA

-11.360755847447862

FCF

-5651000

Fcf Percent

-

Piotroski FScore

0

Health Score

37

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

3

Quality Investing Score

3

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

61000

Quarters > 0 > income Statement > gross Profit

-61000

Quarters > 0 > income Statement > operating Expenses

6314000

Quarters > 0 > income Statement > operating Income

-6375000

Quarters > 0 > income Statement > interest Expense

0

Quarters > 0 > income Statement > pretax Income

-4930000

Quarters > 0 > income Statement > net Income

-4930000

Quarters > 0 > income Statement > eps

-0.06324444273454961

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

77951513

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-4869000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1445000

Quarters > 0 > balance Sheet > cash

39823000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

1900000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

42883000

Quarters > 0 > balance Sheet > property Plant Equipment

512000

Quarters > 0 > balance Sheet > total Assets

43395000

Quarters > 0 > balance Sheet > payables

827000

Quarters > 0 > balance Sheet > short Term Debt

168000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

6866000

Quarters > 0 > balance Sheet > equity

36529000

Quarters > 0 > cash Flow > net Income

-4930000

Quarters > 0 > cash Flow > depreciation

61000

Quarters > 0 > cash Flow > change In Working Capital

-1304000

Quarters > 0 > cash Flow > cash From Operations

-5651000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

33917000

Quarters > 0 > cash Flow > net Change In Cash

28266000

Quarters > 0 > ratios > PE

-0.06324444273454961

Quarters > 0 > ratios > PB

3.6063964786881653

Quarters > 0 > ratios > ROE

-13.496126365353556

Quarters > 0 > ratios > ROA

-11.360755847447862

Quarters > 0 > ratios > FCF

-5651000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

37

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

61000

Quarters > 1 > income Statement > gross Profit

-61000

Quarters > 1 > income Statement > operating Expenses

13978000

Quarters > 1 > income Statement > operating Income

-13978000

Quarters > 1 > income Statement > interest Expense

3000

Quarters > 1 > income Statement > pretax Income

-6734000

Quarters > 1 > income Statement > net Income

-6734000

Quarters > 1 > income Statement > eps

-0.10572931521113402

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

63690945

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-6670000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

7244000

Quarters > 1 > balance Sheet > cash

10743000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

6285000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

19049000

Quarters > 1 > balance Sheet > property Plant Equipment

573000

Quarters > 1 > balance Sheet > total Assets

19622000

Quarters > 1 > balance Sheet > payables

771000

Quarters > 1 > balance Sheet > short Term Debt

239000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

12593000

Quarters > 1 > balance Sheet > equity

7029000

Quarters > 1 > cash Flow > net Income

-6734000

Quarters > 1 > cash Flow > depreciation

61000

Quarters > 1 > cash Flow > change In Working Capital

429000

Quarters > 1 > cash Flow > cash From Operations

-5623000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

752000

Quarters > 1 > cash Flow > net Change In Cash

-4871000

Quarters > 1 > ratios > PE

-0.10572931521113402

Quarters > 1 > ratios > PB

15.313372748612888

Quarters > 1 > ratios > ROE

-95.80310143690426

Quarters > 1 > ratios > ROA

-34.318621954948526

Quarters > 1 > ratios > FCF

-5623000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

25

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

45000

Quarters > 2 > income Statement > gross Profit

-45000

Quarters > 2 > income Statement > operating Expenses

13775000

Quarters > 2 > income Statement > operating Income

-13775000

Quarters > 2 > income Statement > interest Expense

5000

Quarters > 2 > income Statement > pretax Income

-8480000

Quarters > 2 > income Statement > net Income

-8480000

Quarters > 2 > income Statement > eps

-0.13715435666689618

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

61828149

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-8430000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

5295000

Quarters > 2 > balance Sheet > cash

16428000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

4778000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

22866000

Quarters > 2 > balance Sheet > property Plant Equipment

634000

Quarters > 2 > balance Sheet > total Assets

23500000

Quarters > 2 > balance Sheet > payables

1821000

Quarters > 2 > balance Sheet > short Term Debt

355000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

11230000

Quarters > 2 > balance Sheet > equity

12270000

Quarters > 2 > cash Flow > net Income

-8480000

Quarters > 2 > cash Flow > depreciation

45000

Quarters > 2 > cash Flow > change In Working Capital

-2028000

Quarters > 2 > cash Flow > cash From Operations

-9877000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

1296000

Quarters > 2 > cash Flow > net Change In Cash

-8581000

Quarters > 2 > ratios > PE

-0.13715435666689618

Quarters > 2 > ratios > PB

8.515857523227384

Quarters > 2 > ratios > ROE

-69.1116544417278

Quarters > 2 > ratios > ROA

-36.08510638297872

Quarters > 2 > ratios > FCF

-9877000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

250000

Quarters > 3 > income Statement > cost Of Revenue

71000

Quarters > 3 > income Statement > gross Profit

-71000

Quarters > 3 > income Statement > operating Expenses

10723000

Quarters > 3 > income Statement > operating Income

-10723000

Quarters > 3 > income Statement > interest Expense

5000

Quarters > 3 > income Statement > pretax Income

-7842000

Quarters > 3 > income Statement > net Income

-7842000

Quarters > 3 > income Statement > eps

-0.16889452224796583

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

46431346

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7766000

Quarters > 3 > income Statement > operating Margin

-4289.200000000001

Quarters > 3 > income Statement > total Other Income Expense Net

2881000

Quarters > 3 > balance Sheet > cash

25009000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

2686000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

29555000

Quarters > 3 > balance Sheet > property Plant Equipment

679000

Quarters > 3 > balance Sheet > total Assets

30234000

Quarters > 3 > balance Sheet > payables

1984000

Quarters > 3 > balance Sheet > short Term Debt

472000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

11484000

Quarters > 3 > balance Sheet > equity

18750000

Quarters > 3 > cash Flow > net Income

-7842000

Quarters > 3 > cash Flow > depreciation

71000

Quarters > 3 > cash Flow > change In Working Capital

-1145000

Quarters > 3 > cash Flow > cash From Operations

-8382000

Quarters > 3 > cash Flow > capital Expenditures

1000

Quarters > 3 > cash Flow > cash From Investing

-1000

Quarters > 3 > cash Flow > cash From Financing

11381000

Quarters > 3 > cash Flow > net Change In Cash

2998000

Quarters > 3 > ratios > PE

-0.16889452224796583

Quarters > 3 > ratios > PB

4.1850119861333335

Quarters > 3 > ratios > ROE

-41.824

Quarters > 3 > ratios > ROA

-25.93768604881921

Quarters > 3 > ratios > FCF

-8383000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-33.532

Quarters > 3 > health Score

25

Valuation > metrics > PE

-0.06324444273454961

Valuation > metrics > PB

3.6063964786881653

Valuation > final Score

43.936035213118345

Valuation > verdict

20.2% Overvalued

Profitability > metrics > ROE

-13.496126365353556

Profitability > metrics > ROA

-11.496397173705198

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.1879602507596704

Risk > metrics > Interest Coverage

-104.50819672131148

Risk > final Score

-358

Risk > verdict

High

Liquidity > metrics > Current Ratio

43.098492462311555

Liquidity > metrics > Quick Ratio

43.098492462311555

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

38.14988013866667

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-18607

Prev Risks > 1

-10972

Prev Risks > 2

-8530

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:19:53.582Z